In oculopharyngeal muscular dystrophy (OPMD), muscle strength slowly decreases due to a breakdown of muscle cells. Whereas OPMD may affect many muscles, the eyes (oculo) and the throat (pharynx) are disproportionately affected. OPMD is a hereditary muscle disease whose disease mechanism is not yet completely clear. The Biobank OPMD contains clinical data and residual biomaterial from a study where the efficacy of the protein degradation system was investigated in different cell models for OPMD. The study further examined whether recovery from degradation with the aid of medication resulted in less muscle weakness.
-
Want to know more about these subjects? Click on the buttons below for more news.
Related news items
National Biobanks & Collections day
19 October 2023The Health-RI Biobanks & Collections workgroup proudly announces the first National Biobanks & Collections Day. The meeting will take place on November 9 in Amsterdam.
read moreQuality certificate for the PBMC isolation method and cfDNA extraction method
8 August 2023Last year the Radboud Biobank participated for the first time in the IBBL Biospecimen Proficiency Testing program; an external quality assessment tool to verify the precision and accuracy of biospecimen testing methods and the efficiency of processing methods.
read moreTETRO-trial
30 March 2023The TETRO-trial is a study on a new treatment for compulsive/obsessive-compulsive disorder.
read moreArchipelago
30 March 2023Archipelago of Ovarian Cancer Research (AOCR) is a national platform for centralizing and expanding scientific research into ovarian cancer.
read moreTheme Biobank and collections of Health RI launched a new project to develop a novel Dutch Biobank Standard
30 March 2023In February 2023 the theme Biobanks and Collections of Health-RI launched a new project entitled: “Dutch biobanking standard: towards harmonized, evidence-based collection, processing and storage of human biomaterials”.
read moreHealth-RI receives definitive follow-up funding from the National Growth Fund
30 March 2023The full funding of a total of 69 million euros has been definitively awarded to Health-RI, the national health data infrastructure for research and innovation.
read more